The majority of the 30 million diabetic Americans use basic glucose meters that need numerous finger pricks each day and only present the current sugar level, while about 345,000 Americans utilize more-accurate continuous glucose monitoring devices.ĭirector of the Advanced Metabolic Care and Research Institute Dr.Timothy Baileym, who had helped test Freestyle, stated that the majority of diabetics do not perform the finger pricks to calibrate them, leading to inaccurate readings, and he observed that they were able to safely lower blood sugar using FreeStyle.Bailey also receives consulting fees from different diabetes device makers.Īn extremely high blood sugar level can cripple organs and trigger heart attacks, strokes, blindness, and amputations, while an extremely low blood sugar can lead to seizures, confusion, and loss of consciousness.Abbott did not disclose the prices of the reader or the sensors until it gets closer to launching the product, which could be done before 2017 ends.However, Abbott spokeswoman Vicky Assardo said in an email that the price will be "very similar" to Europe's price of about $69 for the reader and $69 for each sensor.Ībbott senior vice president of diabetes care Jared Watkin addressed that the product was designed to be affordable, and added that insurance would frequently cover continuous glucose monitors in the US.Watkin relayed that the company seeks to have talks with US insurers regarding the coverage, and expressed his confidence that insurers will learn of the advantages of covering the device. Present models need users to test a drop of blood twice on a frequent basis to either calibrate or adjust the monitor.Meanwhile, Abbott's FreeStyle Libre Flash Glucose Monitoring System uses a small sensor wire installed below the skin's surface that continuously measures and monitors glucose levels.Users can discover glucose levels by waving a dedicated, mobile reader above the sensor wire to see if glucose levels are either extremely high (hyperglycemia) or extremely low (hypoglycemia), and how glucose levels are changing.The machine was geared for diabetics who are 18 years old and older.The device can be worn for up to 10 days, following a 12-hour start-up period.Īt present, the device has not been approved for use by children, yet Abbott hopes that the FDA will approve it someday. Photo by Piotr Adamowicz via Shutterstock The US Food and Drug Administration regulators have approved Abbott's FreeStyle Libre Flash Glucose Monitoring System, the first continuous blood sugar monitor for diabetics that no longer needs backup finger prick tests.Meaning, Abbott is cleared to sell the device in the US.The device was already sold in 41 other countries.
0 kommentar(er)
